The placement is a bright spot in an otherwise quiet period for psychedelics industry financing, as investors grow selective.
Tryptamine has firm commitments to raise $6m in a placement to advance clinical development of its novel IV-infused psilocin ...
HotCopper.com on MSN12d
Tryptamine to plug $6M Placement funding into acceleration of IV-infused psilocybin treatment trialsTryptamine Therapeutics Ltd (ASX:TYP) is aiming to raise $6 million through a placement to support acceleration of a clinical ...
Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics is undergoing a strategic board reshuffle as Non-Executive ...
Rockville, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- According to a new industry report by Fact.MR, the global tryptamine API market is projected to be worth US$ 757.2 million in 2024 and thereafter ...
Enveric Biosciences expands its patent portfolio with five new U.S. patents, supporting treatments for depression, anxiety ...
Tryptamine receives firm commitments to raise $6m in placement strongly supported by new and existing stakeholders Placement cornerstoned by Merchant Biotech Fund and biotech investor Dr Daniel ...
Followed categories will be added to My News. Tryptamine receives firm commitments to raise $6m in placement strongly supported by new and existing stakeholders Placement cornerstoned by Merchant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback